December 7, 2020
Galbraith MD et al. medRxiv 2020; doi.org/10.1101/2020.12.05.20244442.6.
Seroconversion stages COVID19 into distinct pathophysiological states
You might also be interested by
CellTalk Blog
ELISpot vs. ICS: Optimizing Immune Monitoring in Clinical Trials with the Right Functional Assay
November 19, 2024
Immune Monitoring
More infoCellTalk Blog
Measure Target Engagement With Receptor Occupancy Assays by Flow Cytometry
September 17, 2024
Immune Monitoring
More infoBrochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More info